The final, formatted version of the article will be published soon.
BRIEF RESEARCH REPORT article
Front. Immunol.
Sec. T Cell Biology
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1487530
The origin of human CD20 + T cells: a stolen identity?
Provisionally accepted- Danish Multiple Sclerosis Center (DMSC), Copenhagen, Denmark
Human T cells expressing CD20 play an important role in the defense against virus and cancer and are central in the pathogenesis of both malignancies and various autoimmune disorders. Therapeutic modulation of CD20 + T cells and the CD20 expression level is therefore of significant interest. In rodents, CD20 on T cells is likely the product of an active transfer of CD20 from a donor B cell interacting with a recipient T cell in a process termed trogocytosis. Whether the same applies to human CD20 + T cells is highly debated. Investigating this dispute showed that human CD20 -T cells could achieve CD20 along with a series of other B cell markers from B cells through trogocytosis.However, none of these B cell markers were co-expressed with CD20 on human CD20 + T cells in blood or inflamed CSF, implying that additional mechanisms may be involved in development of human CD20 + T cells. In support of this, we identified true naïve CD20 + T cells, measured endogenous production of CD20 and observed that CD20 could be inherited to daughter cells, contradicting that all human CD20 + T cells are a product of trogocytosis.
Keywords: CD20 + T cells, trogocytosis, endogenous CD20 production, MS4A1, CD20 on proliferating T cells
Received: 28 Aug 2024; Accepted: 04 Nov 2024.
Copyright: © 2024 Von Essen, Stolpe, Bach Søndergaard and Sellebjerg. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Marina R. Von Essen, Danish Multiple Sclerosis Center (DMSC), Copenhagen, Denmark
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.